Qualigen Therapeutics Inc.
QLGN | NASDAQ
$3.21
+$0.17 (+5.59%)
At close: Nov 18, 2025, 04:00 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.63M | 1.61M | n/a | 1.44M | 1.43M | 722.03K | 1.48M | 1.16M | 1.12M | 1.9M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 754.29K | 364.39K | 4.5K | 1.44M | 1.02M | 1.26M | 3.04K | 1.28M | 1.1M | 828.85K | 1.22M | 993.12K | 916.62K | 1.2M |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -754.29K | -364.39K | -4.5K | -1.44M | 610.49K | 342.34K | -3.04K | 163.04K | 330.86K | -106.82K | 260.97K | 161.95K | 201.31K | 697.02K |
Operating Income | -2.96M | -4.33M | -7.36M | -1.43M | -1.68M | -2.72M | -1.33M | -1.27M | -1.74M | -1.42M | -2.27M | -2.78M | -3.55M | -3.69M | -3.44M | -4.38M | -4.14M | -5.01M | -4.65M | -4.81M | -7.39M | -5.81M |
Interest Income | 126.96K | 303.01K | -292.77K | 193.82K | 142.48K | 112.95K | 80.71K | 48.08K | 1.09K | n/a | n/a | n/a | n/a | n/a | n/a | 4.63K | 4.82K | 6.31K | 5.83K | 6.8K | 12.72K | 17.34K |
Pretax Income | -4.19M | -6.08M | -10.6M | -2.04M | -1.69M | -2.65M | -850.29K | -1.8M | -1.48M | -2.03M | -2.47M | -3.24M | -3.58M | -4.27M | -3.6M | -4.06M | -4.12M | -4.32M | -6.06M | -2.86M | -5.3M | -3.67M |
Net Income | -4.19M | -6.08M | -13.16M | -2.04M | -1.69M | -2.65M | -855.82K | -1.79M | -1.58M | -2.03M | -2.47M | -3.66M | -3.46M | -4.11M | -6.37M | -3.83M | -4.13M | -4.32M | -6.06M | -2.86M | -5.31M | -3.67M |
Selling & General & Admin | 2.95M | 4.19M | 3.14M | 1.32M | 1.67M | 2.69M | 1.38M | 1.15M | 986.48K | 1.06M | 958.28K | 1.34M | 2.84M | 1.91M | 2.57M | 2.86M | 2.97M | 3.04M | 3.28M | 2.89M | 3.09M | 3.01M |
Research & Development | 5.07K | 5.07K | 28.24K | 105.58K | 17.82K | 33.17K | -44.94K | 123.43K | 754.29K | 364.39K | 1.31M | 1.44M | 1.33M | 2.12M | 867.69K | 1.69M | 1.51M | 1.86M | 1.63M | 2.08M | 4.51M | 3.5M |
Other Expenses | n/a | 142.57K | n/a | n/a | n/a | n/a | n/a | n/a | -754.29K | -364.39K | n/a | -1.44M | 5.68K | 4.88K | n/a | 1.14K | -376 | n/a | 1.85K | 702 | 2.35K | 542 |
Operating Expenses | 2.96M | 4.33M | 3.17M | 1.43M | 1.68M | 2.72M | 1.33M | 1.27M | 986.48K | 1.06M | 2.27M | 1.34M | 4.16M | 4.04M | 3.43M | 4.55M | 4.47M | 4.9M | 4.91M | 4.97M | 7.6M | 6.51M |
Interest Expense | n/a | n/a | 352.89K | 455.94K | 106.05K | 73.62K | 100.47K | 408.36K | 263.56K | 136.56K | 235.81K | 367.26K | 377.42K | 544.24K | 50.16K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 85.72K | 638.22K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 169.22K | 199.11K | n/a | 239.87K | 305.1K | 138.32K | 140.25K | 130.22K | 135.54K | 136.59K |
Cost & Expenses | 2.96M | 4.33M | -5.84M | 1.43M | 1.68M | 2.72M | 1.33M | 1.27M | 1.74M | 1.42M | 2.27M | 2.78M | 5.18M | 5.3M | 3.44M | 5.82M | 5.57M | 5.73M | 6.13M | 5.96M | 8.51M | 7.71M |
Income Tax Expense | n/a | n/a | 2.56M | n/a | n/a | 35 | 5.53K | -2.2K | -1.21K | 1.79K | -4.79K | n/a | -38.18K | -163.78K | 375 | -230.77K | 5.44K | 736 | 3.28K | 1.01K | 605 | 530 |
Shares Outstanding (Basic) | 20.29M | 7.7M | 2.41M | 1.68M | 1.68M | 1.46M | 4.53M | 4.53M | 7.6M | 5.94M | 5.22M | 5.05M | 5.05M | 4.93M | 4.21M | 3.94M | 3.67M | 3.53M | 3.13M | 2.9M | 2.89M | 2.76M |
Shares Outstanding (Diluted) | 20.29M | 7.7M | 2.41M | 1.68M | 1.68M | 1.46M | 4.53M | 4.53M | 7.6M | 5.94M | 5.23M | 5.05M | 5.05M | 4.96M | 4.21M | 3.94M | 3.67M | 3.53M | 3.13M | 2.9M | 2.89M | 2.82M |
EPS (Basic) | -0.21 | -0.79 | -3.56 | -1.73 | -1 | -1.82 | -0.19 | -0.40 | -0.21 | -0.34 | -0.47 | -0.72 | -0.69 | -0.83 | -2.03 | -0.97 | -1.13 | -1.22 | -1.94 | -0.98 | -1.84 | -1.33 |
EPS (Diluted) | -0.21 | -0.79 | -3.56 | -1.73 | -1 | -1.82 | -0.19 | -0.40 | -0.21 | -0.34 | -0.47 | -0.72 | -0.69 | -0.83 | -2.02 | -0.97 | -1.13 | -1.22 | -1.94 | -0.98 | -1.84 | -1.30 |
EBITDA | -2.96M | -4.33M | -7.36M | -1.58M | -1.58M | -2.57M | -749.83K | -1.39M | -1.74M | -1.42M | -2.23M | -2.71M | -3.05M | -3.61M | -3.55M | -3.38M | -4.05M | -4.92M | -4.56M | -4.73M | -7.32M | -5.74M |
EBIT | -2.96M | -4.33M | 5.73M | -1.58M | -1.58M | -2.57M | -749.83K | -1.39M | -1.74M | -1.42M | -2.24M | -2.78M | -3.17M | -3.73M | -3.55M | -3.47M | -4.14M | -5.01M | -4.65M | -4.81M | -7.39M | -5.81M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.12K | 1.12K | 4.5K | 63.86K | 122.79K | 116.3K | 3.04K | 89.55K | 91.82K | 84.24K | 87.4K | 81.94K | 77.54K | 74.18K |
Add to Watchlist
Select watchlists to add or remove QLGN